A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe
November 24, 2020 at 07:00 AM EST
Rep. Joe Neguse, D-Colo., wants the committee to examine the FTC's common approach to approving pharmaceutical mergers.
